Overview
Compare with Globant, RingCentral or Reddit Inc., or pick any stock.
- TickerCLVT on NYSE1
- IndustryServices-Computer Processing & Data Preparation1
- HeadquartersY91
- Incorporated inJersey2
- Business address4Th Floor, St. Paul'S Gate, 22-24 New Street, St. Helier, Y9 Je14Tr2
- Filer categoryLarge accelerated filer2
See how the biggest companies compare on our leaderboards
The following charts present our revenues for the year ended December 31, 2025 , by segment, type, and geography:4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Subscription Revenues brought in 65% of the revenue CLARIVATE PLC broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Subscription Revenues | $1.6B | $1.6B | $1.6B |
| Re-occurring Revenues | $444.6M | $429.8M | $434.2M |
| Transactional Revenues | $566.1M | $500.1M | $415.5M |
Business segments
Academia & Government Group brought in 52% of the revenue CLARIVATE PLC broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Academia & Government Group | $1.3B | $1.3B | $1.3B |
| Intellectual Property Group | $862.7M | $811.4M | $799.4M |
| Life Sciences and Healthcare Group | $442.8M | $418.9M | $389.8M |
Regions
North America brought in 53% of the revenue CLARIVATE PLC broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| North America | $1.4B | $1.4B | $1.3B |
| EMEA | $707.5M | $667.8M | $654.8M |
| Asia Pacific | $515.8M | $507.5M | $497.4M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue34¢$833.6M
- Selling, general and admin29¢$708.6M
- Other costs37¢$905.8M
- Income tax0¢$7.2M
Out of $2.5B in revenue.5 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending42¢$263.2M
- Kept or used elsewhere58¢$365.3M
Out of $628.5M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenues | $2.5B | $2.6B | $2.6B |
| Cost of revenues | $833.6M | $869.2M | $906.4M |
| Selling, general and administrative costs | $708.6M | $727.6M | $739.7M |
| Depreciation and amortization | $757.2M | $727.0M | $708.3M |
| Goodwill and intangible asset impairments | $15.0M | $540.7M | $979.9M |
| Restructuring and other impairments | $50.7M | $19.6M | $40.0M |
| Other operating expense (income), net | $18.6M | -$51.8M | -$10.8M |
| Total operating expenses | $2.4B | $2.8B | $3.4B |
| Income (loss) from operations | $71.5M | -$275.6M | -$734.7M |
| Fair value adjustment of warrants | $0 | -$5.2M | -$15.9M |
| Interest expense, net | $265.4M | $283.4M | $293.7M |
| Income (loss) before income taxes | -$193.9M | -$553.8M | -$1.0B |
| Provision (benefit) for income taxes | $7.2M | $82.9M | -$101.3M |
| Net income (loss) | -$201.1M | -$636.7M | -$911.2M |
| Dividends on preferred shares | $0 | $31.3M | $75.4M |
| Net income (loss) attributable to ordinary shares | -$201.1M | -$668.0M | -$986.6M |
| Basic (in dollars per share) | -$0.30 | -$0.96 | -$1.47 |
| Diluted (in dollars per share) | -$0.30 | -$0.96 | -$1.47 |
| Basic (in shares) | 673.3M shares | 693.6M shares | 671.6M shares |
| Diluted (in shares) | 673.3M shares | 693.6M shares | 671.6M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents, including restricted cash | $329.2M | $295.2M | ||
| Accounts receivable, net | $821.7M | $798.3M | ||
| Prepaid expenses | $94.2M | $85.9M | ||
| Other current assets | $64.9M | $65.2M | ||
| Total current assets | $1.3B | $1.2B | ||
| Property and equipment, net | $52.7M | $53.5M | ||
| Other intangible assets, net | $8.0B | $8.4B | ||
| Goodwill | $1.6B | $1.6B | $2.0B | |
| Other non-current assets | $68.1M | $82.2M | ||
| Deferred income taxes | $17.2M | $48.5M | ||
| Operating lease right-of-use assets | $46.6M | $53.6M | ||
| Total assets | $11.1B | $11.5B | ||
| Accounts payable | $150.6M | $124.5M | ||
| Accrued compensation | $146.7M | $119.2M | ||
| Accrued expenses and other current liabilities | $273.0M | $308.8M | ||
| Current portion of deferred revenues | $878.6M | $859.1M | ||
| Current portion of operating lease liability | $18.4M | $20.6M | ||
| Total current liabilities | $1.6B | $1.4B | ||
| Long-term debt | $4.3B | $4.5B | ||
| Other non-current liabilities | $86.2M | $72.5M | ||
| Deferred income taxes | $212.1M | $273.3M | ||
| Operating lease liabilities | $37.9M | $53.2M | ||
| Total liabilities | $6.2B | $6.4B | ||
| Ordinary Shares, no par value; unlimited shares authorized; 640.7 and 691.4 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | $12.8B | $13.0B | ||
| Accumulated other comprehensive loss | -$453.1M | -$526.3M | ||
| Accumulated deficit | -$7.5B | -$7.3B | ||
| Total shareholders' equity | $4.8B | $5.1B | $6.0B | $6.8B |
| Total liabilities and shareholders' equity | $11.1B | $11.5B | ||
| Current portion of long-term debt(1) | $101.5M | $1.3M | ||
| Ordinary shares, par value (in dollars per share) | $0.00 | $0.00 | ||
| Ordinary shares, issued (in shares) | 640.7M shares | 691.4M shares | ||
| Ordinary shares, outstanding (in shares) | 640.7M shares | 691.4M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents, including restricted cash | $329.2M | $295.2M | ||
| Accounts receivable, net | $821.7M | $798.3M | ||
| Prepaid expenses | $94.2M | $85.9M | ||
| Other current assets | $64.9M | $65.2M | ||
| Total current assets | $1.3B | $1.2B | ||
| Property and equipment, net | $52.7M | $53.5M | ||
| Other intangible assets, net | $8.0B | $8.4B | ||
| Goodwill | $1.6B | $1.6B | $2.0B | |
| Other non-current assets | $68.1M | $82.2M | ||
| Deferred income taxes | $17.2M | $48.5M | ||
| Operating lease right-of-use assets | $46.6M | $53.6M | ||
| Total assets | $11.1B | $11.5B | ||
| Accounts payable | $150.6M | $124.5M | ||
| Accrued compensation | $146.7M | $119.2M | ||
| Accrued expenses and other current liabilities | $273.0M | $308.8M | ||
| Current portion of deferred revenues | $878.6M | $859.1M | ||
| Current portion of operating lease liability | $18.4M | $20.6M | ||
| Total current liabilities | $1.6B | $1.4B | ||
| Long-term debt | $4.3B | $4.5B | ||
| Other non-current liabilities | $86.2M | $72.5M | ||
| Deferred income taxes | $212.1M | $273.3M | ||
| Operating lease liabilities | $37.9M | $53.2M | ||
| Total liabilities | $6.2B | $6.4B | ||
| Ordinary Shares, no par value; unlimited shares authorized; 640.7 and 691.4 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | $12.8B | $13.0B | ||
| Accumulated other comprehensive loss | -$453.1M | -$526.3M | ||
| Accumulated deficit | -$7.5B | -$7.3B | ||
| Total shareholders' equity | $4.8B | $5.1B | $6.0B | $6.8B |
| Total liabilities and shareholders' equity | $11.1B | $11.5B | ||
| Current portion of long-term debt(1) | $101.5M | $1.3M | ||
| Ordinary shares, par value (in dollars per share) | $0.00 | $0.00 | ||
| Ordinary shares, issued (in shares) | 640.7M shares | 691.4M shares | ||
| Ordinary shares, outstanding (in shares) | 640.7M shares | 691.4M shares |
Every line of the cash flow as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | -$201.1M | -$636.7M | -$911.2M |
| Depreciation and amortization | $757.2M | $727.0M | $708.3M |
| Share-based compensation | $63.1M | $59.9M | $109.0M |
| Restructuring and other impairments, including goodwill | $18.6M | $540.3M | $986.2M |
| Gain on sale from divestitures | $0 | -$54.7M | $0 |
| Gain on legal settlement | $0 | $0 | -$49.4M |
| Deferred income taxes | -$41.5M | $21.2M | -$78.4M |
| Amortization and write-off of debt issuance costs | $14.3M | $16.4M | $18.2M |
| Other operating activities | $14.4M | -$1.9M | $21.9M |
| Accounts receivable | -$5.0M | $92.6M | -$25.5M |
| Prepaid expenses | -$7.5M | $1.5M | $1.7M |
| Other assets | $3.2M | -$800.0K | $35.1M |
| Accounts payable | $22.8M | -$15.0M | $41.2M |
| Accrued expenses and other current liabilities | -$11.3M | $3.8M | -$44.4M |
| Deferred revenues | -$2.6M | -$106.2M | $20.3M |
| Operating leases, net | -$5.4M | -$9.6M | -$8.0M |
| Other liabilities | $9.3M | $8.8M | -$80.8M |
| Net cash provided by operating activities | $628.5M | $646.6M | $744.2M |
| Capital expenditures | -$263.2M | -$289.1M | -$242.5M |
| Payments to Acquire Businesses, Net of Cash Acquired | $0 | -$32.0M | -$5.4M |
| Proceeds from divestitures, net of cash divested | $0 | $84.4M | $10.5M |
| Net cash used for investing activities | -$263.2M | -$236.7M | -$237.4M |
| Principal payments on debt | -$600.0M | -$198.1M | -$300.0M |
| Proceeds from Issuance of Debt | $500.0M | $0 | $0 |
| Payment of debt issuance and extinguishment costs | -$9.4M | -$20.1M | $100.0K |
| Payments for Repurchase of Equity | $224.5M | $200.0M | $100.0M |
| Cash dividends on preferred shares | $0 | -$37.7M | -$75.5M |
| Payments related to tax withholding for share-based compensation | -$10.4M | -$15.6M | -$20.6M |
| Other financing activities | $1.2M | $1.4M | -$500.0K |
| Net cash used for financing activities | -$343.1M | -$470.1M | -$496.5M |
| Effects of exchange rates | $11.8M | -$15.3M | $3.6M |
| Net change in cash and cash equivalents, including restricted cash | $34.0M | -$75.5M | $13.9M |
| Cash paid for interest | $256.3M | $265.3M | $273.5M |
| Cash paid for income tax | $42.1M | $52.9M | $42.9M |
No quarter-by-quarter statement was filed.
Corporate structure
CLARIVATE PLC sits at the top of its group. 157 entities, 32 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of CLARIVATE PLC
- Clarkston Capital Partners, LLC Filed SCHEDULE 13G/A on CLARIVATE PLC, latest May 14, 2026 (4 filings since Feb 14, 2023)
- Impactive Capital LP Filed SCHEDULE 13D/A on CLARIVATE PLC, latest Feb 6, 2026 (2 filings since Oct 16, 2023)
- BAUPOST GROUP LLC/MA Filed SCHEDULE 13G/A on CLARIVATE PLC, latest May 14, 2025 (2 filings since Nov 13, 2024)
- N.v. Exor Filed SC 13D/A on CLARIVATE PLC, latest Mar 4, 2024 (5 filings since Oct 23, 2023)
- GENERATION INVESTMENT MANAGEMENT LLP Filed SC 13G/A on CLARIVATE PLC, latest Feb 14, 2024 (5 filings since Dec 7, 2021)
- PRICE T ROWE ASSOCIATES INC /MD/ Filed SC 13G/A on CLARIVATE PLC, latest Feb 14, 2023 (2 filings since Feb 14, 2022)
- Select Equity Group, L.P. Filed SC 13G/A on CLARIVATE PLC, latest Feb 14, 2023 (2 filings since Feb 14, 2022)
- Farallon Capital Partners, L.P. Filed SC 13G/A on CLARIVATE PLC, latest Feb 7, 2023 (2 filings since Sep 7, 2022)
- Onex Corporation Filed SC 13G/A on CLARIVATE PLC, latest Feb 10, 2022
- FMR LLC Filed SC 13G/A on CLARIVATE PLC, latest Feb 9, 2022
- CLARIVATE PLC Y9
- Annui GmbH Subsidiary · Germany
- BlackB Srl Subsidiary · Belgium
- C.P.A. Limited Subsidiary · Jersey
- Camelot Deutschland GmbH Subsidiary · Germany
- Camelot Finance S.A. Subsidiary · Luxembourg
- Camelot Holdco 3 (Jersey) Limited Subsidiary · Jersey
- Camelot Holdings (Jersey) Limited Subsidiary · Jersey
- Camelot Professional K.K. Subsidiary · Japan
- Camelot Spain, S.L.U. Subsidiary · Spain
- Camelot U.S. Acquisition 2 Co. Subsidiary · Delaware, United States
- Camelot U.S. Acquisition 4 Co. Subsidiary · Delaware, United States
- Camelot U.S. Acquisition LLC Subsidiary · Delaware, United States
- Camelot UK Bidco Limited Subsidiary · United Kingdom
- Camelot UK Holdco 2 Limited Subsidiary · United Kingdom
- Camelot UK Holdco Limited Subsidiary · United Kingdom
- Camelot UK Top Holdco Limited Subsidiary · United Kingdom
- Camelot US Acquisitions 3 Co. Subsidiary · Delaware, United States
- Cee-Bo Global IP Management Services (Shenzhen) Limited Subsidiary · China
- Cee-Bo Landon Information Consulting (Shanghai) Limited Subsidiary · China
- Centre for Innovation in Regulatory Science Limited Subsidiary · United Kingdom
- Centre for Medicines Research International Limited Subsidiary · United Kingdom
- Clarivate (Chengdu) Technology Co., Ltd. Subsidiary · China
- Clarivate (Guangzhou) Technology Co., Ltd. Subsidiary · China
- Clarivate (Jinan) Technology Co., Ltd. Subsidiary · China
- Clarivate (Malaysia) Sdn. Bhd. Subsidiary · Malaysia
- and 131 more
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What CLARIVATE PLC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Operating-lease assets (leased space) | $46.6M5 Dec 31, 2025 | $53.6M5 Dec 31, 2024 | −13.1% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $329.2M5 Dec 31, 2025 | $295.2M5 Dec 31, 2024 | +11.5% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $1.6B5 Dec 31, 2025 | $1.6B5 Dec 31, 2024 | 0% |
| Intangible assets, net (excluding goodwill) | $8.0B5 Dec 31, 2025 | $8.4B5 Dec 31, 2024 | −5.1% |
| Finite-lived intangibles, gross | $12.0B5 Dec 31, 2025 | $11.7B5 Dec 31, 2024 | +2.8% |
| Accumulated amortization | $4.2B5 Dec 31, 2025 | $3.4B5 Dec 31, 2024 | +22.5% |
| Finite-lived intangibles, net | $7.9B5 Dec 31, 2025 | $8.3B5 Dec 31, 2024 | −5.2% |
Properties, in its own words
Our corporate headquarters is located in the leased premises located at 70 St. Mary Axe, London EC3A 8BE, United
Kingdom. We lease office facilities at 41 locations around the world, of which 7 are in the United States. We believe that our
The rest of Item 2
facilities, generally used across each of our segments, are well maintained and are suitable and adequate for our current
needs.
Item 2 of the 10-K filed Feb 24, 2026.4
Leadership
Who has led CLARIVATE PLC, and when. Pick a name to see everywhere that person has worked.
President
Chief financial officer
- Chief executive officerTov Matitiahu S. Shem Aug 15, 2024 to now15
- Chief executive officerJonathan Gear Jul 18, 2022 to Jul 15, 202416
- Chief executive officerJerre L. Stead Dec 31, 2020 to Mar 3, 202217
- ChairJerre L. Stead Dec 31, 2020 to Mar 3, 202217
- PresidentSimon Webster Jun 12, 2026 to now18
- PresidentMaroun S. Mourad Sep 16, 2025 to Jun 12, 202619
- PresidentBar Veinstein May 2, 2023 to Sep 16, 202520
- PresidentHenry Levy May 2, 2023 to Sep 16, 202521
- PresidentJames Gordon Samson Jul 14, 2021 to May 2, 202322
- PresidentJeff Roy Dec 31, 2020 to Jun 15, 202123
- PresidentMukhtar Ahmed Dec 31, 2020 to Apr 4, 202224
- Chief financial officerMichael M. Easton Aug 18, 2026 to now25
- Chief financial officerRichard Hanks Dec 31, 2020 to Jun 15, 202126
Board members and other officers (33)
- Senior VP, CAOMatthew J. Lisowski Aug 14, 2026 to now27
- EVP, Chief Information OfficerWilliam E. Graff Apr 8, 2024 to now28
- EVP, Chief Admin & Legal OffcrMelanie Margolin Aug 15, 2024 to Sep 17, 202429
- Chief Product OfficerJames Gordon Samson Mar 3, 2022 to Mar 3, 202330
- Chief Technology OfficerStefano Maestri Apr 4, 2022 to Mar 3, 202331
- Senior VP, Finance/CAOMichael M. Easton Jun 13, 2022 to now32
- Chief People OfficerJulie M. Wilson Apr 14, 2021 to May 17, 202433
- Chief Revenue OfficerSteen Lomholt-Thomsen Aug 9, 2021 to Mar 3, 202334
- Acting Chief Acctg OfficerHeather Matzke-Hamlin Oct 12, 2021 to Mar 3, 202235
- Chief Accounting OfficerChristine E. Archbold Dec 31, 2020 to Mar 3, 202236
- Board memberKenneth L. Cornick Jul 24, 2025 to now37
- Board memberSuzanne Elizabeth Heywood May 8, 2024 to now38
- Board memberTov Matitiahu S. Shem Aug 15, 2024 to now15
- Board memberSaurabh Saha May 8, 2023 to now39
- Board memberJonathan Gear Jul 18, 2022 to Jul 15, 202416
- Board memberWendell E. Pritchett Jul 29, 2022 to now40
- Board memberRoxane White May 10, 2021 to Oct 4, 202241
- Board memberValeria Alberola May 10, 2021 to now42
- Board memberAndrew Miles Snyder Dec 3, 2021 to now43
- Board memberMichael J. Angelakis Dec 3, 2021 to now44
- Board memberAdam Levyn Dec 31, 2020 to Dec 31, 202045
- Board memberAnthony Munk Dec 31, 2020 to Dec 31, 202046
- Board memberBalakrishnan S. Iyer Dec 31, 2020 to Oct 4, 202247
- Board memberBlucher Sheryl G. Von Dec 31, 2020 to May 8, 202348
- Board memberCharles J. Neral Dec 31, 2020 to May 9, 202249
- Board memberJane L. Okun Dec 31, 2020 to now50
- Board memberKosty Gilis Dec 31, 2020 to Dec 31, 202051
- Board memberNicholas Macksey Dec 31, 2020 to Dec 31, 202052
- Board memberRichard Roedel Dec 31, 2020 to Jan 3, 202553
- Board memberUsama Cortas Dec 31, 2020 to Jun 23, 202154
- Board memberVii Capri Aiv L.p. Gei Dec 31, 2020 to Jun 23, 202155
- General counselMelanie Margolin Sep 19, 2023 to Mar 19, 202456
- General counselJaspal Chahal Jul 14, 2021 to Aug 17, 202357
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Annui GmbH Germany3
- BlackB Srl Belgium3
- C.P.A. Limited Jersey3
- CPA Global (Asia) Limited Hong Kong3
- CPA Global (Australia) Pty Ltd Australia3
- CPA Global (FIP) LLC Delaware3
- CPA Global (FTF) Inc. Delaware3
- CPA Global (IPAN) LLC Delaware3
- CPA Global (Ipendo Systems) AB Sweden3
- CPA Global (Ipendo) AB Sweden3
- CPA Global (Ipendo) Inc. Delaware3
- CPA Global (Korea) LLC South Korea3
- CPA Global (Landon IP) Inc. Virginia3
- CPA Global (Landon IP) Limited England and Wales3
- CPA Global (Patrafee) AB Sweden3
- CPA Global (Patrafee) Limited England and Wales3
- CPA Global Deutschland GmbH Germany3
- CPA Global Group Holdings Limited Jersey3
- CPA Global Holdings (France) SNC France3
- CPA Global IP Management Consulting (Taiwan) Co., Ltd Taiwan3
- CPA Global Limited Jersey3
- CPA Global Management Services Limited England and Wales3
- CPA Global North America LLC Delaware3
- CPA Global Patent Research LLC Virginia3
All 164 listed subsidiaries
- CPA Global Renewals (UK) Limited England and Wales3
- CPA Global Services Private Limited India3
- CPA Global Services US Inc Delaware3
- CPA Global Software Solutions (UK) Limited England and Wales3
- CPA Global Software Solutions Australia Pty Limited Australia3
- CPA Global Software Solutions SAS France3
- CPA Global Support Services India Private Limited India3
- CPA Global Support Services LLC Delaware3
- CPA Global Sweden Holdings AB Sweden3
- CPA Global d.o.o. Beograd-Stari Grad Serbia3
- CPA US Holdings, Inc Delaware3
- CPAUSH Limited England and Wales3
- Camelot Deutschland GmbH Germany3
- Camelot Finance S.A. Luxembourg3
- Camelot Holdco 3 (Jersey) Limited Jersey3
- Camelot Holdings (Jersey) Limited Jersey3
- Camelot Professional K.K. Japan3
- Camelot Spain, S.L.U. Spain3
- Camelot U.S. Acquisition 2 Co. Delaware3
- Camelot U.S. Acquisition 4 Co. Delaware3
- Camelot U.S. Acquisition LLC Delaware3
- Camelot UK Bidco Limited England and Wales3
- Camelot UK Holdco 2 Limited England and Wales3
- Camelot UK Holdco Limited England and Wales3
- Camelot UK Top Holdco Limited England and Wales3
- Camelot US Acquisitions 3 Co. Delaware3
- Cee-Bo Global IP Management Services (Shenzhen) Limited China3
- Cee-Bo Landon Information Consulting (Shanghai) Limited China3
- Centre for Innovation in Regulatory Science Limited England and Wales3
- Centre for Medicines Research International Limited England and Wales3
- Clarivate (Chengdu) Technology Co., Ltd. China3
- Clarivate (Guangzhou) Technology Co., Ltd. China3
- Clarivate (Jinan) Technology Co., Ltd. China3
- Clarivate (Malaysia) Sdn. Bhd. Malaysia3
- Clarivate (Suzhou) Technology Co., Ltd. China3
- Clarivate (Wuhan) Technology Co., Ltd. China3
- Clarivate (Xian) Technology Co., Ltd. China3
- Clarivate Analytics (Australia) Holdings Pty Limited Australia3
- Clarivate Analytics (Australia) Pty Limited Australia3
- Clarivate Analytics (Beijing) Technology Company Ltd. China3
- Clarivate Analytics (Belgium) N.V. Belgium3
- Clarivate Analytics (Canada) Corp. Canada3
- Clarivate Analytics (Compumark) Inc. Delaware3
- Clarivate Analytics (Compumark) Limited England and Wales3
- Clarivate Analytics (Compumark) SAS France3
- Clarivate Analytics (Deutschland) GmbH Germany3
- Clarivate Analytics (España), S.A.U. Spain3
- Clarivate Analytics (France) Holdings SAS France3
- Clarivate Analytics (France) SAS France3
- Clarivate Analytics (India) Private Limited India3
- Clarivate Analytics (International) Limited England and Wales3
- Clarivate Analytics (Italia) S.r.l. Italy3
- Clarivate Analytics (Japan) Co. Ltd. Japan3
- Clarivate Analytics (New Zealand) Holdings Limited New Zealand3
- Clarivate Analytics (Singapore) Pte. Ltd. Singapore3
- Clarivate Analytics (Taiwan) Co., Ltd. Taiwan3
- Clarivate Analytics (UK) Limited England and Wales3
- Clarivate Analytics (US) Holdings Inc. Delaware3
- Clarivate Analytics (US) LLC Delaware3
- Clarivate Analytics Information Services (Beijing) Co. Ltd. China3
- Clarivate Analytics Korea Ltd. South Korea3
- Clarivate Analytics Mexico, S.A. de C.V. Mexico3
- Clarivate EL Corporation Delaware3
- Clarivate IP (US) Holdings Corporation Delaware3
- Clarivate IP Services Limited Scotland3
- Clarivate Science Holdings Corporation Delaware3
- Clarivate Servicos Analiticos Brasil Ltda. Brazil3
- Clarivate U.S. Science Holdings Corporation Delaware3
- Computer Patent Annuities International Limited England and Wales3
- Crossbow IP Services LLC Delaware3
- DARTS-IP SRL Belgium3
- DR/Decision Resources, LLC Delaware3
- DRG Analytics & Insights Private Limited India3
- DRG Holdco Inc. Delaware3
- Decision Resources, Inc. Delaware3
- Discovery Logic, Inc. Delaware3
- Ex Libris (Australia) Pty. Ltd. Australia3
- Ex Libris (Deutschland) GmbH Germany3
- Ex Libris (France) Sarl France3
- Ex Libris (Scandinavia) A/S Denmark3
- Ex Libris (UK) Limited England and Wales3
- Ex Libris (USA) Inc New York3
- Ex Libris Asia Pacific Pte. Ltd. Singapore3
- Ex Libris Global Holdings, Inc. Delaware3
- Ex Libris Group Holdings Corp. Delaware3
- Ex Libris Group LLC Delaware3
- Ex Libris Israeli Holdco Ltd. Israel3
- Ex Libris Italy S.r.l. Italy3
- Ex Libris Ltd. Israel3
- Ex Libris Software Science & Technology Development (Beijing) Co. Ltd. China3
- Hanlim IPS Co. Ltd. South Korea3
- III Acquisition Corp. Delaware3
- IP Folio Corporation Delaware3
- IPAN BPM GmbH Germany3
- IPAN GmbH Germany3
- IPAN Service GmbH Germany3
- IPSS Europe Limited England and Wales3
- Information Ventures LLC Delaware3
- Innography, Inc Delaware3
- Innovative Interfaces Canada Inc. Canada3
- Innovative Interfaces Incorporated California3
- Innovative Interfaces International Limited England and Wales3
- Innovative Interfaces Ireland Limited Ireland3
- Innovative Interfaces Limited England and Wales3
- Landon IP (HK) Limited Hong Kong3
- Longbow Legal Limited Hong Kong3
- Longbow Legal Services Inc Delaware3
- Longbow Legal Services Private Limited India3
- Markpro Co. South Korea3
- Markpro Global Company (Japanese: Markpro Japan K.K.) Japan3
- Markpro US LLC Delaware3
- Master Data Center Inc Michigan3
- MicroPatent LLC Delaware3
- Millennium Research Group Inc Canada3
- Pi2 Solutions Limited England and Wales3
- ProQuest Chile S.p.A. Chile3
- ProQuest Colombia S.A.S. Colombia3
- ProQuest European Holdings Limited England and Wales3
- ProQuest Information and Learning LLC Delaware3
- ProQuest Information and Learning Limited England and Wales3
- ProQuest LATAM, Sociedad de R.L. de C.V. Mexico3
- ProQuest LLC Delaware3
- ProQuest LP Maryland3
- ProQuest Latin America Servicos E Produtos Para Acesso A Informacao Ltda. Brazil3
- ProQuest Netherlands B.V. Netherlands3
- ProQuest Pension Trustee Limited England and Wales3
- ProQuest UK Holdings Limited England and Wales3
- Publons Limited New Zealand3
- Research Research (Africa) Pty Limited South Africa3
- Research Research Limited England and Wales3
- Rowan TELS Corp. Delaware3
- See-Out Pty Limited Australia3
- Selige Investments S.a.r.l. Luxembourg3
- Sigmatic Limited England and Wales3
- Trademark Vision USA, LLC Delaware3
- Unycom GmbH Austria3
- Unycom Management Services GmbH Austria3
- VTLS, Inc. Virginia3
- WIRO Limited England and Wales3
- Zarabatana Solucoes Em Informatica Ltda. Brazil3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- Clarivate Analytics PLCJan 14, 2019 to May 4, 20202
Timeline
- Oct 13, 20268-K Completed an acquisition or sale58
- Oct 6, 20268-K Completed an acquisition or sale; Executive or director change; Other events59
- Sep 24, 20268-K Other events60
- Sep 23, 20268-K Other events61
- Sep 17, 20268-K Other events62
- Jul 29, 20268-K Results of operations; Regulation FD disclosure63
- Jul 29, 20268-K Executive or director change; Regulation FD disclosure64
- Jul 6, 20268-K Regulation FD disclosure65
- Jul 6, 20268-K Entered a material agreement; Executive or director change66
- Jun 8, 20268-K Executive or director change; Regulation FD disclosure67
- May 18, 20268-K Shareholder vote; Other events68
- Apr 29, 20268-K Results of operations; Regulation FD disclosure69
- Aug 15, 2024New chief executive Tov Matitiahu S. Shem becomes CEO15
- Jul 18, 2022New chief executive Jonathan Gear becomes CEO16
- Dec 31, 2020New chief executive Jerre L. Stead becomes CEO17
Calendar
Coming up
- Nov 3, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported $0.16 a share, on Oct 29, 2025.70
When it reported results
- Jul 29, 2026Reported quarterly or annual results63
- Apr 29, 2026Reported quarterly or annual results69
- Feb 24, 2026Reported quarterly or annual results71
- Oct 29, 2025Reported quarterly or annual results72
- Jul 30, 2025Reported quarterly or annual results73
- Apr 29, 2025Reported quarterly or annual results74
- Feb 19, 2025Reported quarterly or annual results75
- Nov 6, 2024Reported quarterly or annual results76
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
446 filings to the SEC since October 2021: 7 annual reports, 18 quarterly reports, 80 major events, 278 insider forms, 26 large holders, 37 other. The latest 20:
- Oct 13, 20268-K/A EDGAR
- Oct 8, 20264 EDGAR
- Oct 6, 20268-K EDGAR
- Oct 2, 20264 EDGAR
- Oct 2, 20264 EDGAR
- Oct 2, 20264 EDGAR
- Sep 24, 20268-K EDGAR
- Sep 23, 20268-K EDGAR
- Sep 17, 20268-K EDGAR
- Aug 18, 20264 EDGAR
- Aug 18, 20264 EDGAR
- Aug 17, 20264 EDGAR
- Aug 14, 20263 EDGAR
- Aug 10, 20264 EDGAR
- Aug 5, 20264 EDGAR
- Aug 3, 2026144 EDGAR
- Jul 29, 20268-K EDGAR
- Jul 29, 202610-Q EDGAR
- Jul 29, 20268-K EDGAR
- Jul 6, 20268-K EDGAR
The 446 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
34 open-market trades by officers, directors and large owners since October 2021: 18 buys and 16 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Cornick Kenneth L.Director | Buy | 250,000 | $1.85 | $462.5K | Form 4 |
| Aug 6, 2026 | Cornick Kenneth L.Director | Buy | 650,000 | $1.86 | $1.2M | Form 4 |
| Aug 3, 2026 | Snyder Andrew MilesDirector | Sale | 2,489,618 | $1.94 | $4.8M | Form 4 |
| Dec 1, 2025 | Veinstein BarPresident, A&G | Sale | 309,902 | $3.74 | $1.2M | Form 4 |
| Nov 10, 2025 | Cornick Kenneth L.Director | Buy | 100,000 | $3.45 | $345.0K | Form 4 |
| Nov 3, 2025 | Cornick Kenneth L.Director | Buy | 225,000 | $3.52 | $792.0K | Form 4 |
| Oct 31, 2025 | Cornick Kenneth L.Director | Buy | 500,000 | $3.38 | $1.7M | Form 4 |
| Oct 31, 2025 | Snyder Andrew MilesDirector | Buy | 1,460,000 | $3.33 | $4.9M | Form 4 |
| Aug 1, 2025 | Cornick Kenneth L.Director | Buy | 165,000 | $3.74 | $617.1K | Form 4 |
| Jul 1, 2025 | Samson James GordonPresident, IP | Sale | 100,000 | $4.53 | $453.0K | Form 4 |
| Mar 14, 2025 | Snyder Andrew MilesDirector | Buy | 237,176 | $4.17 | $989.0K | Form 4 |
| Mar 12, 2025 | Bomba Jane L OkunDirector | Buy | 49,750 | $4.03 | $200.5K | Form 4 |
| Mar 3, 2025 | Pritchett Wendell E.Director | Buy | 22,857 | $4.38 | $100.1K | Form 4 |
| Mar 3, 2025 | SAHA SAURABHDirector | Buy | 58,275 | $4.36 | $254.1K | Form 4 |
| Nov 22, 2024 | Angelakis Michael JDirector | Buy | 765,000 | $5.19 | $4.0M | Form 4 |
| Nov 21, 2024 | Angelakis Michael JDirector | Buy | 1,200,000 | $5.19 | $6.2M | Form 4 |
| Nov 20, 2024 | Angelakis Michael JDirector | Buy | 1,500,000 | $5.11 | $7.7M | Form 4 |
| Oct 15, 2024 | Veinstein BarPresident, A&G | Sale | 60,000 | $7.00 | $420.0K | Form 4 |
| Sep 19, 2024 | Veinstein BarPresident, A&G | Sale | 120,000 | $7.00 | $840.0K | Form 4 |
| Aug 30, 2024 | SAHA SAURABHDirector | Sale | 17,646 | $6.75 | $119.1K | Form 4 |
All 34 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Clarkston Capital Partners, LLCSCHEDULE 13G/A, 4 filings Feb 14, 2023 to May 14, 202677
- Impactive Capital LPSCHEDULE 13D/A, 2 filings Oct 16, 2023 to Feb 6, 202678
- BAUPOST GROUP LLC/MASCHEDULE 13G/A, 2 filings Nov 13, 2024 to May 14, 202579
- N.v. ExorSC 13D/A, 5 filings Oct 23, 2023 to Mar 4, 202480
- GENERATION INVESTMENT MANAGEMENT LLPSC 13G/A, 5 filings Dec 7, 2021 to Feb 14, 202481
- PRICE T ROWE ASSOCIATES INC /MD/SC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 202382
- Select Equity Group, L.P.SC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 202383
- Farallon Capital Partners, L.P.SC 13G/A, 2 filings Sep 7, 2022 to Feb 7, 202384
- Onex CorporationSC 13G/A, 1 filing Feb 10, 202285
- FMR LLCSC 13G/A, 1 filing Feb 9, 202286
Members of Congress who traded it
2 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Jul 12, 2023 | Daniel S. GoldmanDemocratic, House | Sale | $1,001 - $15,000 | +155.1% | Report |
| Nov 30, 2022 | Susie LeeDemocratic, House | Sale | $1,001 - $15,000 | +171.2% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
SEC filer profile
How CLARIVATE PLC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARCLARIVATE PLC1
- CIK0001764046
- Employer ID (EIN)00-00000004
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company4
- Incorporated inJersey4
- Fiscal year endsDecember 311
- Industry code (SIC)7374 Services-Computer Processing & Data Preparation1
- SEC reviewing officeOffice of Technology, Division of Corporation Finance1
- Business address4Th Floor, St. Paul'S Gate, 22-24 New Street, St. Helier, Y9 JE14TR1
- Mailing address70 St. Mary Axe, London, X0 EC3A 8BE1
- Phone(207) 433-40001
- Shares outstanding639,216,510 as of Mar 31, 202610
- Public float$1.3B as of Jun 30, 20254
- AuditorPricewaterhouseCoopers LLP, Philadelphia, Pennsylvania PCAOB ID 238; it also attests to the company’s internal control over financial reporting4
- On EDGAR sinceJan 14, 20191
- Filings687 in all: 4 (304), 8-K (111), 3 (48), 10-Q (20), CORRESP (18), 6-K (16), SC 13G/A (15), SC 13G (11)1
All 49 form types
UPLOAD (10), EFFECT (9), 10-K (7), 425 (7), DEF 14A (7), 144 (6), 424B3 (6), 424B4 (6), DEFA14A (6), SC 13D/A (6), 8-K/A (5), 424B5 (4), ARS (4), CERT (4), DRS (4), F-4/A (4), PRE 14A (4), SC 13D (4), 10-K/A (3), 10-Q/A (3), 25-NSE (3), 8-A12B (3), F-1 (3), POS AM (3), S-8 (3), F-1MEF (2), S-3 (2), S-3ASR (2), SCHEDULE 13G/A (2), 20-F (1), 20-F/A (1), 4/A (1), 424B1 (1), 8-A12B/A (1), F-4 (1), IRANNOTICE (1), NT 10-K (1), S-1 (1), S-1MEF (1), S-3MEF (1), SCHEDULE 13D/A (1)
- Latest filingsAnnual report (10-K) Feb 24, 2026
Quarterly report (10-Q) Jul 29, 2026
Proxy statement (DEF 14A) Apr 1, 2026
Latest 8-K (8-K) Oct 6, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Ordinary Shares, no par value | CLVT | New York Stock Exchange |
From the cover page of the 10-K filed Feb 24, 2026 (Section 12(b) of the Exchange Act).4
Risk factors and legal proceedings
The risks CLARIVATE PLC names in Item 1A of its 10-K filed Feb 24, 2026: 41 risks under these headings, as written.4
- Strategy and Market Risks
- We are dependent on third parties, including public sources, for data, information, and other services, and our
- relationships with such third parties may not be successful or may change, which could adversely affect our results of
- Increased access to free or relatively inexpensive information sources may reduce demand for our products and services.
- We operate in a highly competitive industry, and we may be adversely affected by competition and other changes in our
- We generate a significant percentage of our revenues from recurring subscription-based arrangements and highly
- predictable re-occurring arrangements. If we are unable to maintain a high annual renewal rate for our subscription-
- based and re-occurring arrangements, our results of operations could be adversely affected.
- If our products and services do not achieve and maintain broad market acceptance, or if we are unable to keep pace with
- or adapt to rapidly changing technology, evolving industry standards, and changing regulatory requirements, our
- revenues could be adversely affected.
- Reductions in customers’ research budgets or government funding may adversely affect our business.
The other 30 risks
- Business and Operational Risks
- Our Value Creation Plan may not be successful and may not lead to increased shareholder value.
- The loss of, or the inability to attract and retain, key personnel could impair our ability to execute our business strategy
- and achieve future success.
- Our business continuity and recovery plans may not be effective against events that may adversely impact our business.
- We may be unable to derive fully the anticipated benefits from organic growth, existing or future acquisitions, joint
- ventures, investments, or dispositions, including anticipated revenue and cost synergies, and costs associated with
- achieving synergies or integrating such acquisitions may exceed our expectations.
- The international scope of our operations may expose us to increased risk, and our international operations and corporate
- and financing structure may expose us to potentially adverse tax consequences.
- We face risks associated with having operations and employees located in Israel.
- Our brand and reputation are key assets and competitive advantages for us, and our business may be affected by how we
- are perceived in the marketplace.
- Our indebtedness could adversely affect our business, financial condition, and results of operations.
- We have incurred goodwill impairment charges and may incur future impairment charges for our goodwill and other
- intangible assets, which would negatively impact our operating results.
- Intellectual Property, Data Privacy, and Cybersecurity Risks
- Failure to obtain, maintain, protect, defend, or enforce our intellectual property and other proprietary rights could
- adversely affect our business, financial condition, and results of operations.
- Uncertainty in the development, deployment, and use of AI in our products and services may result in operational or
- reputational damage, competitive harm, liability, and additional costs, any of which could adversely affect our business,
- financial condition, and results of operations.
- We face risks related to the regulation of AI and other evolving technologies.
- Any disruption in or unauthorized access to or breaches of our computer systems or those of third parties that we utilize in
- our operations, including those relating to cybersecurity or arising from cyberattacks, could adversely impact our
- Our collection, storage, and use of confidential, sensitive, or personal information or data are subject to applicable data
- privacy and cybersecurity laws, and any failure to comply with such laws may harm our reputation and business or expose
- us to fines and other enforcement action.
- Intellectual property litigation, including litigation related to content provided using our products and services, could
- result in reputational damage and significant costs, and could adversely affect our business, financial condition, and
- results of operations.
- Our use of “open source” software could negatively affect our ability to offer our solutions and subject us to possible
Legal proceedings
From time to time, we are a party to various lawsuits, claims, and other legal proceedings that arise in the ordinary course of
our business. While the outcomes of these matters are uncertain, management does not expect that the ultimate costs to
resolve these matters will have a material adverse effect on our consolidated financial position, results of operations, or cash
flows. For additional discussion of legal proceedings, see Note 16 - Commitments and Contingencies included in Part II, Item
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCLARIVATE PLC filings on SEC EDGAR
- 2SEC EDGARCLARIVATE PLC filings on SEC EDGAR
- 3
- 4
- 5SEC EDGARCLARIVATE PLC 10-K for fiscal 2025
- 6SEC EDGARCLARIVATE PLC 10-K for fiscal 2019
- 7SEC EDGARCLARIVATE PLC 10-K for fiscal 2020
- 8SEC EDGARCLARIVATE PLC 10-K for fiscal 2021
- 9SEC EDGARCLARIVATE PLC 10-K for fiscal 2022
- 10SEC EDGARCLARIVATE PLC 10-Q for fiscal 2025
- 11SEC EDGARCLARIVATE PLC 10-Q for fiscal 2025
- 12SEC EDGARCLARIVATE PLC 10-Q for fiscal 2025
- 13SEC EDGARCLARIVATE PLC 10-K for fiscal 2019
- 14SEC EDGARCLARIVATE PLC 10-Q for fiscal 2025
- 15
- 16
- 17
- 18SEC EDGARSimon Webster, President
- 19SEC EDGARMaroun S. Mourad, President
- 20SEC EDGARBar Veinstein, President
- 21SEC EDGARHenry Levy, President
- 22SEC EDGARJames Gordon Samson, President
- 23SEC EDGARJeff Roy, President
- 24SEC EDGARMukhtar Ahmed, President
- 25
- 26
- 27SEC EDGARMatthew J. Lisowski, Senior VP, CAO
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37SEC EDGARKenneth L. Cornick, Board member
- 38
- 39SEC EDGARSaurabh Saha, Board member
- 40SEC EDGARWendell E. Pritchett, Board member
- 41SEC EDGARRoxane White, Board member
- 42SEC EDGARValeria Alberola, Board member
- 43SEC EDGARAndrew Miles Snyder, Board member
- 44SEC EDGARMichael J. Angelakis, Board member
- 45SEC EDGARAdam Levyn, Board member
- 46SEC EDGARAnthony Munk, Board member
- 47SEC EDGARBalakrishnan S. Iyer, Board member
- 48SEC EDGARBlucher Sheryl G. Von, Board member
- 49SEC EDGARCharles J. Neral, Board member
- 50SEC EDGARJane L. Okun, Board member
- 51SEC EDGARKosty Gilis, Board member
- 52SEC EDGARNicholas Macksey, Board member
- 53SEC EDGARRichard Roedel, Board member
- 54SEC EDGARUsama Cortas, Board member
- 55SEC EDGARVii Capri Aiv L.p. Gei, Board member
- 56SEC EDGARMelanie Margolin, General counsel
- 57SEC EDGARJaspal Chahal, General counsel
- 58SEC EDGARCompleted an acquisition or sale
- 59
- 60SEC EDGAROther events
- 61SEC EDGAROther events
- 62SEC EDGAROther events
- 63
- 64
- 65SEC EDGARRegulation FD disclosure
- 66
- 67
- 68SEC EDGARShareholder vote; Other events
- 69
- 70NasdaqNasdaq calendar
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80SEC EDGARN.v. Exor SC 13D/A on CLARIVATE PLC
- 81
- 82
- 83
- 84
- 85
- 86SEC EDGARFMR LLC SC 13G/A on CLARIVATE PLC